← back to search

Simon J. Ogrodnik

German Cancer Research Center · DE
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, and Genetic factors in colorectal cancer.
h-index
7
citations
170
works
10
NIH funding
primary concept
email

Recent publications

Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer
Journal of Experimental & Clinical Cancer Research 2025cited by 11position: middledoi
Early circulating tumor <scp>DNA</scp> changes predict outcomes in head and neck cancer patients under re‐radiotherapy
International Journal of Cancer 2024cited by 7position: middledoi
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC
Hepatology 2023cited by 7position: middledoi
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
npj Precision Oncology 2021cited by 35position: middledoi
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
EBioMedicine 2020cited by 46position: middledoi
Abstract A21: Longitudinal analysis of cell-free DNA for therapy monitoring of ALK-positive non-small cell lung cancer
Clinical Cancer Research 2020cited by 0position: middledoi
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
Cancers 2019cited by 41position: middledoi
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1–ALK</i>-rearranged lung cancer
Molecular Case Studies 2019cited by 23position: middledoi
TP53 status conversion defines an unfavourable patient subset with inferior overall survival in ALK+ lung adenocarcinoma
Pneumologie 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Holger Sültmann · German Cancer Research Center8 papers (2019–2025)Petros Christopoulos · Torbay Hospital7 papers (2019–2025)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg7 papers (2019–2025)Michael Meister · Heidelberg University6 papers (2019–2021)Steffen Dietz · Deutschen Konsortium für Translationale Krebsforschung6 papers (2019–2021)Michael Thomas · Barwon Health6 papers (2019–2021)Tomasz Żemojtel · Berlin Institute of Health at Charité - Universitätsmedizin Berlin5 papers (2019–2020)Volker Endris · Deutschen Konsortium für Translationale Krebsforschung5 papers (2019–2020)Zhao Yuan · Qinghai University4 papers (2019–2021)Matthias Schlesner · University of Augsburg4 papers (2019–2021)Marc A. Schneider · Heidelberg University4 papers (2019–2021)Anna‐Lena Volckmar · Heidelberg University4 papers (2019–2020)Florian Janke · German Cancer Research Center4 papers (2020–2025)Arlou Kristina Angeles · German Cancer Research Center4 papers (2020–2025)Lisa Gu · Southwestern Medical Center3 papers (2019–2020)Martin Reck · St. Luke's Clinic3 papers (2019–2020)Thomas Muley · Heidelberg University3 papers (2019–2020)Claus Peter Heußel · Heidelberg University2 papers (2019–2019)Sabrina Gerhardt · German Cancer Research Center2 papers (2024–2025)Magdalena Görtz · German Cancer Research Center2 papers (2024–2025)